Patent · US Active

Treatment of prostate cancer

US9156878B2 · kind B2 · utility

7Cited by
8References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 24, 2014
Grant dateOct 13, 2015
Priority date
Expiry dateJun 24, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07J43/003
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Described herein are compounds, methods of making such compounds, pharmaceutical compositions, and medicaments comprising such compounds, and methods of using such compounds to treat androgen receptor mediated diseases or conditions. The present invention provides therapies and therapeutic regimens for the treatment of prostate cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.